Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BeiGene doses first patient in phase 1b/2 trial of ZW25 in HER2-positive breast cancer and GEA
BeiGene doses first patient in phase 1b/2 trial of ZW25 in HER2-positive breast cancer and GEA. (Credit: Belova59 from Pixabay)
BeiGene doses first patient in phase 1b/2 trial of ZW25 in HER2-positive breast cancer and GEA. (Credit: Belova59 from Pixabay)